Angela Bryan
Concepts (520)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sexual Behavior | 42 | 2023 | 487 | 8.500 |
Why?
| | Risk-Taking | 27 | 2023 | 354 | 6.630 |
Why?
| | Exercise | 34 | 2024 | 2024 | 5.460 |
Why?
| | Adolescent Behavior | 24 | 2021 | 536 | 5.340 |
Why?
| | Condoms | 28 | 2021 | 104 | 4.970 |
Why?
| | Alcohol Drinking | 29 | 2025 | 824 | 4.910 |
Why?
| | Cannabis | 20 | 2025 | 490 | 4.870 |
Why?
| | Sexually Transmitted Diseases | 18 | 2021 | 158 | 4.480 |
Why?
| | Marijuana Abuse | 16 | 2025 | 234 | 4.410 |
Why?
| | Marijuana Use | 11 | 2025 | 203 | 4.390 |
Why?
| | Cannabidiol | 11 | 2025 | 119 | 4.350 |
Why?
| | Juvenile Delinquency | 16 | 2016 | 109 | 4.020 |
Why?
| | Intention | 15 | 2021 | 171 | 3.910 |
Why?
| | Dronabinol | 16 | 2025 | 230 | 3.820 |
Why?
| | Marijuana Smoking | 15 | 2023 | 250 | 3.580 |
Why?
| | Substance-Related Disorders | 16 | 2023 | 1079 | 2.830 |
Why?
| | Affect | 13 | 2025 | 310 | 2.760 |
Why?
| | Motivation | 23 | 2023 | 571 | 2.560 |
Why?
| | Health Behavior | 18 | 2023 | 764 | 2.530 |
Why?
| | Risk Reduction Behavior | 8 | 2021 | 220 | 2.460 |
Why?
| | Attitude | 8 | 2021 | 262 | 2.240 |
Why?
| | HIV Infections | 22 | 2023 | 2830 | 2.220 |
Why?
| | Sexual and Gender Minorities | 4 | 2024 | 213 | 2.080 |
Why?
| | Adolescent | 93 | 2025 | 21555 | 2.000 |
Why?
| | Young Adult | 63 | 2025 | 13243 | 1.900 |
Why?
| | Male | 140 | 2025 | 67718 | 1.810 |
Why?
| | Female | 147 | 2025 | 73162 | 1.800 |
Why?
| | Health Promotion | 11 | 2023 | 744 | 1.780 |
Why?
| | Unsafe Sex | 7 | 2018 | 59 | 1.740 |
Why?
| | Brain | 17 | 2020 | 2831 | 1.650 |
Why?
| | Humans | 188 | 2025 | 137514 | 1.650 |
Why?
| | Self Efficacy | 11 | 2018 | 396 | 1.630 |
Why?
| | Psychological Theory | 7 | 2021 | 98 | 1.610 |
Why?
| | Health Knowledge, Attitudes, Practice | 11 | 2020 | 1332 | 1.570 |
Why?
| | Adult | 93 | 2025 | 37821 | 1.510 |
Why?
| | Cognition | 8 | 2023 | 1192 | 1.490 |
Why?
| | Body Mass Index | 8 | 2024 | 2369 | 1.470 |
Why?
| | Homosexuality, Male | 4 | 2023 | 182 | 1.440 |
Why?
| | Cross-Over Studies | 2 | 2023 | 561 | 1.420 |
Why?
| | Prisoners | 6 | 2018 | 145 | 1.410 |
Why?
| | Safe Sex | 7 | 2020 | 23 | 1.260 |
Why?
| | Diet | 4 | 2024 | 1273 | 1.180 |
Why?
| | Anxiety | 4 | 2025 | 1041 | 1.170 |
Why?
| | Alcoholism | 14 | 2023 | 805 | 1.150 |
Why?
| | Hallucinogens | 8 | 2022 | 105 | 1.130 |
Why?
| | Fruit | 2 | 2019 | 138 | 1.120 |
Why?
| | Mindfulness | 4 | 2024 | 122 | 1.120 |
Why?
| | Exercise Therapy | 5 | 2022 | 435 | 1.110 |
Why?
| | Vegetables | 2 | 2019 | 155 | 1.100 |
Why?
| | Personal Satisfaction | 2 | 2024 | 211 | 1.090 |
Why?
| | Magnetic Resonance Imaging | 22 | 2021 | 3722 | 1.080 |
Why?
| | Running | 3 | 2023 | 198 | 1.030 |
Why?
| | Attitude to Health | 6 | 2018 | 444 | 0.990 |
Why?
| | Interpersonal Relations | 2 | 2024 | 411 | 0.970 |
Why?
| | Surveys and Questionnaires | 30 | 2025 | 5772 | 0.950 |
Why?
| | Puberty | 2 | 2018 | 146 | 0.940 |
Why?
| | Behavioral Medicine | 2 | 2023 | 36 | 0.930 |
Why?
| | DNA Methylation | 6 | 2024 | 644 | 0.920 |
Why?
| | Saliva | 4 | 2025 | 242 | 0.920 |
Why?
| | Feeding Behavior | 4 | 2019 | 652 | 0.910 |
Why?
| | Alcohol-Related Disorders | 6 | 2021 | 124 | 0.900 |
Why?
| | Yoga | 1 | 2024 | 31 | 0.890 |
Why?
| | Overweight | 3 | 2021 | 554 | 0.890 |
Why?
| | Decision Making | 5 | 2018 | 906 | 0.880 |
Why?
| | Physical Fitness | 4 | 2020 | 208 | 0.850 |
Why?
| | Anti-Anxiety Agents | 1 | 2024 | 46 | 0.850 |
Why?
| | Health Education | 7 | 2009 | 343 | 0.840 |
Why?
| | Middle Aged | 44 | 2025 | 33355 | 0.840 |
Why?
| | Posture | 1 | 2024 | 185 | 0.830 |
Why?
| | Brain Mapping | 6 | 2018 | 610 | 0.830 |
Why?
| | Flowers | 5 | 2024 | 64 | 0.800 |
Why?
| | Underage Drinking | 3 | 2021 | 22 | 0.790 |
Why?
| | Cues | 5 | 2019 | 335 | 0.770 |
Why?
| | Sexual Health | 1 | 2023 | 59 | 0.760 |
Why?
| | Coitus | 2 | 2020 | 25 | 0.750 |
Why?
| | Reward | 5 | 2018 | 257 | 0.750 |
Why?
| | Longitudinal Studies | 14 | 2021 | 2857 | 0.740 |
Why?
| | Students | 11 | 2021 | 625 | 0.720 |
Why?
| | Executive Function | 5 | 2020 | 457 | 0.720 |
Why?
| | Smoking Cessation | 4 | 2017 | 447 | 0.720 |
Why?
| | Behavior Therapy | 4 | 2023 | 262 | 0.710 |
Why?
| | Medical Marijuana | 2 | 2020 | 117 | 0.710 |
Why?
| | High-Intensity Interval Training | 1 | 2020 | 25 | 0.690 |
Why?
| | Varenicline | 2 | 2017 | 25 | 0.680 |
Why?
| | Sexual Partners | 3 | 2024 | 191 | 0.660 |
Why?
| | Attentional Bias | 1 | 2019 | 10 | 0.650 |
Why?
| | Attention | 3 | 2020 | 453 | 0.650 |
Why?
| | Depression | 2 | 2024 | 1408 | 0.650 |
Why?
| | Cannabinoids | 4 | 2022 | 161 | 0.640 |
Why?
| | Parietal Lobe | 2 | 2019 | 60 | 0.630 |
Why?
| | Sex Offenses | 2 | 2020 | 195 | 0.630 |
Why?
| | Prisons | 2 | 2013 | 81 | 0.630 |
Why?
| | Irritable Bowel Syndrome | 1 | 2019 | 29 | 0.620 |
Why?
| | Pain | 2 | 2024 | 836 | 0.610 |
Why?
| | Models, Psychological | 9 | 2018 | 311 | 0.610 |
Why?
| | Delay Discounting | 2 | 2018 | 23 | 0.600 |
Why?
| | Motivational Interviewing | 4 | 2023 | 104 | 0.600 |
Why?
| | Sex Education | 2 | 2016 | 29 | 0.590 |
Why?
| | Cocaine-Related Disorders | 1 | 2019 | 113 | 0.590 |
Why?
| | Motor Activity | 2 | 2013 | 723 | 0.580 |
Why?
| | Limbic System | 1 | 2018 | 48 | 0.570 |
Why?
| | Reaction Time | 2 | 2019 | 432 | 0.570 |
Why?
| | Obesity | 5 | 2023 | 2974 | 0.570 |
Why?
| | Body Weight Maintenance | 1 | 2017 | 16 | 0.560 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2020 | 544 | 0.550 |
Why?
| | Nerve Net | 2 | 2018 | 284 | 0.550 |
Why?
| | Adolescent Development | 1 | 2018 | 88 | 0.540 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2019 | 179 | 0.540 |
Why?
| | Inflammation | 3 | 2025 | 2837 | 0.540 |
Why?
| | Homosexuality, Female | 2 | 2015 | 39 | 0.530 |
Why?
| | Sequence Analysis, DNA | 1 | 2020 | 812 | 0.520 |
Why?
| | Cerebral Cortex | 2 | 2018 | 459 | 0.520 |
Why?
| | Tobacco Use Disorder | 2 | 2017 | 252 | 0.520 |
Why?
| | Insulin Resistance | 1 | 2025 | 1198 | 0.520 |
Why?
| | Smoking | 7 | 2017 | 1639 | 0.520 |
Why?
| | Aggression | 3 | 2015 | 210 | 0.510 |
Why?
| | Corpus Striatum | 1 | 2018 | 166 | 0.510 |
Why?
| | Crime Victims | 2 | 2018 | 129 | 0.510 |
Why?
| | Genotype | 8 | 2014 | 1920 | 0.510 |
Why?
| | Follow-Up Studies | 13 | 2018 | 5139 | 0.510 |
Why?
| | Feedback, Psychological | 1 | 2016 | 23 | 0.500 |
Why?
| | Cognitive Neuroscience | 1 | 2016 | 12 | 0.500 |
Why?
| | Video Games | 1 | 2016 | 27 | 0.490 |
Why?
| | Psychotherapy | 1 | 2017 | 165 | 0.490 |
Why?
| | Public Policy | 2 | 2015 | 82 | 0.490 |
Why?
| | Research Design | 5 | 2019 | 1116 | 0.490 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 2 | 2017 | 423 | 0.480 |
Why?
| | Feeding and Eating Disorders | 2 | 2014 | 152 | 0.470 |
Why?
| | Randomized Controlled Trials as Topic | 5 | 2024 | 1465 | 0.470 |
Why?
| | Temporal Lobe | 1 | 2015 | 91 | 0.470 |
Why?
| | Psychometrics | 7 | 2025 | 723 | 0.460 |
Why?
| | Criminals | 2 | 2014 | 36 | 0.460 |
Why?
| | Risk Factors | 14 | 2017 | 10356 | 0.460 |
Why?
| | Coercion | 1 | 2014 | 10 | 0.460 |
Why?
| | Shame | 1 | 2014 | 14 | 0.450 |
Why?
| | Mental Disorders | 2 | 2019 | 1083 | 0.450 |
Why?
| | Psychotherapy, Group | 3 | 2009 | 66 | 0.450 |
Why?
| | Brain-Derived Neurotrophic Factor | 3 | 2014 | 134 | 0.450 |
Why?
| | United States | 15 | 2024 | 14696 | 0.450 |
Why?
| | Love | 2 | 2011 | 12 | 0.450 |
Why?
| | Research Subjects | 1 | 2014 | 42 | 0.450 |
Why?
| | Body Image | 2 | 2014 | 96 | 0.440 |
Why?
| | Gymnastics | 1 | 2014 | 22 | 0.440 |
Why?
| | Trust | 1 | 2015 | 123 | 0.440 |
Why?
| | Criminal Law | 1 | 2014 | 31 | 0.440 |
Why?
| | Patient Dropouts | 1 | 2014 | 67 | 0.440 |
Why?
| | Oxygen Consumption | 3 | 2023 | 684 | 0.420 |
Why?
| | Self Report | 7 | 2021 | 831 | 0.420 |
Why?
| | Program Evaluation | 4 | 2013 | 892 | 0.410 |
Why?
| | Physical Exertion | 4 | 2023 | 212 | 0.410 |
Why?
| | Bacteria | 1 | 2020 | 858 | 0.410 |
Why?
| | Patient Compliance | 2 | 2014 | 586 | 0.400 |
Why?
| | Biomedical Research | 1 | 2019 | 689 | 0.400 |
Why?
| | Mobile Applications | 1 | 2016 | 180 | 0.400 |
Why?
| | Breast Neoplasms | 2 | 2017 | 2249 | 0.400 |
Why?
| | Regression Analysis | 6 | 2016 | 1029 | 0.400 |
Why?
| | Mental Health | 1 | 2019 | 724 | 0.390 |
Why?
| | Task Performance and Analysis | 2 | 2015 | 186 | 0.390 |
Why?
| | Heterosexuality | 3 | 2011 | 43 | 0.390 |
Why?
| | Social Norms | 3 | 2018 | 30 | 0.390 |
Why?
| | Colorado | 11 | 2016 | 4521 | 0.380 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 696 | 0.380 |
Why?
| | Cell Phone | 1 | 2012 | 75 | 0.370 |
Why?
| | Substance Abuse Treatment Centers | 1 | 2012 | 40 | 0.370 |
Why?
| | Cross-Sectional Studies | 10 | 2021 | 5427 | 0.370 |
Why?
| | Receptors, Dopamine D2 | 4 | 2018 | 98 | 0.370 |
Why?
| | Weight Loss | 2 | 2021 | 770 | 0.360 |
Why?
| | Courtship | 1 | 2011 | 10 | 0.360 |
Why?
| | Social Desirability | 1 | 2011 | 15 | 0.360 |
Why?
| | Peer Group | 4 | 2020 | 244 | 0.350 |
Why?
| | Social Dominance | 1 | 2011 | 21 | 0.350 |
Why?
| | Self-Control | 2 | 2024 | 56 | 0.350 |
Why?
| | Health Risk Behaviors | 2 | 2020 | 16 | 0.340 |
Why?
| | Gray Matter | 3 | 2021 | 83 | 0.340 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 1279 | 0.340 |
Why?
| | Factor Analysis, Statistical | 5 | 2025 | 287 | 0.340 |
Why?
| | Reproducibility of Results | 11 | 2025 | 3292 | 0.340 |
Why?
| | Research | 3 | 2015 | 446 | 0.330 |
Why?
| | Genomics | 2 | 2012 | 793 | 0.320 |
Why?
| | Universities | 5 | 2020 | 432 | 0.320 |
Why?
| | Emotions | 3 | 2025 | 590 | 0.320 |
Why?
| | Adaptation, Psychological | 1 | 2014 | 653 | 0.310 |
Why?
| | Polymorphism, Single Nucleotide | 5 | 2014 | 2193 | 0.300 |
Why?
| | White Matter | 2 | 2021 | 148 | 0.300 |
Why?
| | Phenotype | 6 | 2022 | 3205 | 0.290 |
Why?
| | Psychotic Disorders | 2 | 2022 | 167 | 0.290 |
Why?
| | Depressive Disorder, Major | 1 | 2012 | 366 | 0.280 |
Why?
| | Impulsive Behavior | 5 | 2017 | 150 | 0.280 |
Why?
| | Urban Population | 2 | 2009 | 475 | 0.280 |
Why?
| | Testosterone | 1 | 2011 | 399 | 0.280 |
Why?
| | Models, Statistical | 2 | 2012 | 667 | 0.270 |
Why?
| | Software | 1 | 2012 | 670 | 0.270 |
Why?
| | Aged | 11 | 2024 | 23798 | 0.270 |
Why?
| | Antipsychotic Agents | 2 | 2022 | 196 | 0.270 |
Why?
| | Fatigue | 3 | 2016 | 329 | 0.260 |
Why?
| | Individuality | 2 | 2009 | 171 | 0.260 |
Why?
| | Sleep | 2 | 2024 | 754 | 0.250 |
Why?
| | Prospective Studies | 6 | 2018 | 7598 | 0.250 |
Why?
| | Life Style | 3 | 2017 | 485 | 0.250 |
Why?
| | Treatment Outcome | 12 | 2022 | 10821 | 0.240 |
Why?
| | Pilot Projects | 4 | 2022 | 1703 | 0.240 |
Why?
| | Eicosanoids | 1 | 2025 | 62 | 0.230 |
Why?
| | Gender Identity | 2 | 2023 | 124 | 0.230 |
Why?
| | Cluster Analysis | 2 | 2018 | 502 | 0.220 |
Why?
| | Autonomic Nervous System | 1 | 2024 | 80 | 0.220 |
Why?
| | Meditation | 1 | 2024 | 39 | 0.220 |
Why?
| | Pleasure | 1 | 2023 | 21 | 0.220 |
Why?
| | Minority Health | 1 | 2023 | 20 | 0.210 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2024 | 113 | 0.210 |
Why?
| | Progesterone | 1 | 2025 | 251 | 0.210 |
Why?
| | Sex Factors | 7 | 2019 | 2074 | 0.210 |
Why?
| | Logistic Models | 2 | 2007 | 2064 | 0.210 |
Why?
| | Double-Blind Method | 3 | 2024 | 1987 | 0.200 |
Why?
| | Hydrocortisone | 1 | 2025 | 318 | 0.200 |
Why?
| | Body Weight | 2 | 2017 | 973 | 0.200 |
Why?
| | Automobile Driving | 2 | 2007 | 147 | 0.200 |
Why?
| | Cooking | 1 | 2023 | 62 | 0.200 |
Why?
| | Ethanol | 3 | 2021 | 608 | 0.200 |
Why?
| | Weight Lifting | 1 | 2002 | 34 | 0.190 |
Why?
| | Exercise Test | 2 | 2017 | 621 | 0.190 |
Why?
| | Exploratory Behavior | 4 | 2015 | 91 | 0.180 |
Why?
| | Effect Modifier, Epidemiologic | 1 | 2021 | 13 | 0.180 |
Why?
| | Prevalence | 4 | 2024 | 2719 | 0.180 |
Why?
| | Anti-Inflammatory Agents | 1 | 2025 | 498 | 0.180 |
Why?
| | Tobacco Use | 2 | 2019 | 66 | 0.180 |
Why?
| | Analysis of Variance | 5 | 2011 | 1324 | 0.180 |
Why?
| | Sleep Wake Disorders | 1 | 2024 | 283 | 0.180 |
Why?
| | Receptors, Dopamine D4 | 4 | 2009 | 26 | 0.180 |
Why?
| | Age Factors | 5 | 2024 | 3301 | 0.170 |
Why?
| | Heart Rate | 3 | 2025 | 831 | 0.170 |
Why?
| | Peer Influence | 1 | 2020 | 10 | 0.170 |
Why?
| | Sexuality | 2 | 1997 | 32 | 0.170 |
Why?
| | Sensation Disorders | 1 | 2020 | 34 | 0.170 |
Why?
| | Occupations | 1 | 2000 | 48 | 0.170 |
Why?
| | Ecological Momentary Assessment | 1 | 2020 | 36 | 0.170 |
Why?
| | Appetite | 1 | 2020 | 68 | 0.170 |
Why?
| | Multivariate Analysis | 3 | 2012 | 1524 | 0.170 |
Why?
| | Neuropsychological Tests | 4 | 2018 | 1066 | 0.170 |
Why?
| | Behavior, Addictive | 2 | 2019 | 83 | 0.160 |
Why?
| | DNA, Ribosomal | 1 | 2020 | 86 | 0.160 |
Why?
| | Occupational Diseases | 1 | 2001 | 157 | 0.160 |
Why?
| | CpG Islands | 2 | 2017 | 160 | 0.160 |
Why?
| | Heroin Dependence | 1 | 2000 | 33 | 0.160 |
Why?
| | Socioeconomic Factors | 3 | 2015 | 1286 | 0.160 |
Why?
| | Aging | 2 | 2024 | 1866 | 0.160 |
Why?
| | Drug and Narcotic Control | 1 | 2019 | 28 | 0.160 |
Why?
| | Diet Surveys | 1 | 2019 | 95 | 0.160 |
Why?
| | Knowledge | 1 | 2019 | 53 | 0.160 |
Why?
| | Migraine Disorders | 1 | 2020 | 104 | 0.150 |
Why?
| | Self Concept | 2 | 2014 | 260 | 0.150 |
Why?
| | Methadone | 1 | 2000 | 98 | 0.150 |
Why?
| | Statistics as Topic | 2 | 2012 | 316 | 0.150 |
Why?
| | Suicidal Ideation | 1 | 2024 | 523 | 0.150 |
Why?
| | DNA, Bacterial | 1 | 2020 | 336 | 0.150 |
Why?
| | Hostility | 2 | 2015 | 15 | 0.150 |
Why?
| | Plant Extracts | 1 | 2020 | 203 | 0.150 |
Why?
| | Cancer Survivors | 1 | 2023 | 280 | 0.150 |
Why?
| | Social Behavior | 2 | 2018 | 300 | 0.150 |
Why?
| | Self Disclosure | 2 | 2009 | 63 | 0.150 |
Why?
| | Taste | 2 | 2018 | 234 | 0.140 |
Why?
| | Anger | 2 | 2015 | 61 | 0.140 |
Why?
| | Chronic Pain | 1 | 2022 | 275 | 0.140 |
Why?
| | Hyperkinesis | 1 | 2017 | 17 | 0.140 |
Why?
| | Internal-External Control | 1 | 1997 | 71 | 0.140 |
Why?
| | Information Dissemination | 1 | 2019 | 218 | 0.140 |
Why?
| | Drinking | 1 | 2017 | 42 | 0.140 |
Why?
| | Polymorphism, Genetic | 3 | 2008 | 658 | 0.130 |
Why?
| | Alcoholic Beverages | 1 | 2017 | 30 | 0.130 |
Why?
| | Cigarette Smoking | 1 | 2018 | 102 | 0.130 |
Why?
| | Cannabinoid Receptor Agonists | 3 | 2021 | 46 | 0.130 |
Why?
| | Cytokines | 1 | 2025 | 2095 | 0.130 |
Why?
| | Stress, Psychological | 1 | 2025 | 1115 | 0.130 |
Why?
| | Transcriptome | 1 | 2023 | 974 | 0.130 |
Why?
| | Single Person | 1 | 1996 | 8 | 0.130 |
Why?
| | Prefrontal Cortex | 1 | 2019 | 336 | 0.130 |
Why?
| | Psychiatric Status Rating Scales | 3 | 2014 | 555 | 0.130 |
Why?
| | Southwestern United States | 2 | 2017 | 90 | 0.130 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 403 | 0.120 |
Why?
| | Nicotinic Agonists | 1 | 2017 | 130 | 0.120 |
Why?
| | Nutrition Surveys | 1 | 2017 | 268 | 0.120 |
Why?
| | Social Discrimination | 1 | 2015 | 13 | 0.120 |
Why?
| | Nucleus Accumbens | 2 | 2015 | 141 | 0.120 |
Why?
| | Social Justice | 1 | 2016 | 78 | 0.120 |
Why?
| | Mental Recall | 1 | 2016 | 204 | 0.120 |
Why?
| | Cognitive Dysfunction | 1 | 2020 | 386 | 0.120 |
Why?
| | Conduct Disorder | 1 | 2017 | 201 | 0.120 |
Why?
| | Genetic Predisposition to Disease | 1 | 2004 | 2420 | 0.120 |
Why?
| | Neuroimaging | 1 | 2017 | 291 | 0.120 |
Why?
| | Incidence | 2 | 2020 | 2792 | 0.110 |
Why?
| | Goals | 1 | 2016 | 168 | 0.110 |
Why?
| | Athletic Performance | 1 | 2015 | 76 | 0.110 |
Why?
| | Protective Factors | 1 | 2014 | 94 | 0.110 |
Why?
| | Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2013 | 26 | 0.110 |
Why?
| | Retinal Dehydrogenase | 1 | 2013 | 30 | 0.110 |
Why?
| | Personality Inventory | 4 | 2011 | 142 | 0.110 |
Why?
| | Anisotropy | 1 | 2013 | 80 | 0.110 |
Why?
| | Epigenesis, Genetic | 2 | 2024 | 660 | 0.110 |
Why?
| | Benzodiazepines | 1 | 2014 | 153 | 0.100 |
Why?
| | Diffusion Tensor Imaging | 1 | 2013 | 80 | 0.100 |
Why?
| | Models, Economic | 1 | 2013 | 57 | 0.100 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2013 | 47 | 0.100 |
Why?
| | India | 3 | 2007 | 193 | 0.100 |
Why?
| | Norepinephrine | 1 | 2013 | 212 | 0.100 |
Why?
| | Body Temperature | 1 | 2013 | 221 | 0.100 |
Why?
| | Auditory Perception | 1 | 2013 | 118 | 0.100 |
Why?
| | Artifacts | 1 | 2013 | 137 | 0.100 |
Why?
| | Body Weights and Measures | 1 | 2012 | 36 | 0.100 |
Why?
| | Lactic Acid | 1 | 2013 | 306 | 0.090 |
Why?
| | Connecticut | 3 | 2008 | 27 | 0.090 |
Why?
| | Comorbidity | 2 | 2012 | 1618 | 0.090 |
Why?
| | Residential Treatment | 1 | 2012 | 30 | 0.090 |
Why?
| | Microbiota | 1 | 2020 | 763 | 0.090 |
Why?
| | Visual Perception | 1 | 2013 | 169 | 0.090 |
Why?
| | Sex Characteristics | 2 | 2021 | 766 | 0.090 |
Why?
| | Speech | 1 | 2012 | 77 | 0.090 |
Why?
| | Interview, Psychological | 1 | 2012 | 98 | 0.090 |
Why?
| | Nursing Research | 1 | 2012 | 48 | 0.090 |
Why?
| | Secondary Prevention | 2 | 2023 | 233 | 0.090 |
Why?
| | Receptor, Muscarinic M2 | 1 | 2011 | 9 | 0.090 |
Why?
| | Sampling Studies | 1 | 2011 | 100 | 0.090 |
Why?
| | Minnesota | 1 | 2012 | 161 | 0.090 |
Why?
| | Authoritarianism | 1 | 2011 | 9 | 0.090 |
Why?
| | Radiography | 1 | 2014 | 834 | 0.090 |
Why?
| | Genetic Markers | 1 | 2012 | 345 | 0.090 |
Why?
| | Child | 5 | 2015 | 22037 | 0.090 |
Why?
| | Beauty | 1 | 2011 | 19 | 0.090 |
Why?
| | Interviews as Topic | 2 | 2007 | 767 | 0.090 |
Why?
| | Cost-Benefit Analysis | 1 | 2013 | 593 | 0.090 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2013 | 279 | 0.090 |
Why?
| | Cognition Disorders | 1 | 2014 | 517 | 0.080 |
Why?
| | Anorexia Nervosa | 1 | 2011 | 86 | 0.080 |
Why?
| | Menstrual Cycle | 1 | 2011 | 131 | 0.080 |
Why?
| | Odorants | 1 | 2011 | 156 | 0.080 |
Why?
| | Photic Stimulation | 2 | 2013 | 254 | 0.080 |
Why?
| | Forecasting | 1 | 2011 | 386 | 0.080 |
Why?
| | Smell | 1 | 2011 | 146 | 0.080 |
Why?
| | Genome, Human | 1 | 2012 | 424 | 0.080 |
Why?
| | Craving | 2 | 2023 | 41 | 0.080 |
Why?
| | Genetic Variation | 2 | 2012 | 986 | 0.080 |
Why?
| | Minisatellite Repeats | 3 | 2008 | 42 | 0.080 |
Why?
| | Pregnancy in Adolescence | 1 | 2009 | 81 | 0.080 |
Why?
| | Psychotherapy, Brief | 1 | 2009 | 34 | 0.080 |
Why?
| | Internet | 1 | 2013 | 656 | 0.080 |
Why?
| | Alcoholic Intoxication | 1 | 2009 | 66 | 0.080 |
Why?
| | Biological Evolution | 1 | 2012 | 466 | 0.080 |
Why?
| | Recurrence | 1 | 2012 | 1060 | 0.070 |
Why?
| | Neoplasms | 1 | 2023 | 2666 | 0.070 |
Why?
| | Social Conformity | 1 | 2007 | 12 | 0.070 |
Why?
| | Proteins | 1 | 2013 | 1012 | 0.070 |
Why?
| | Computers | 1 | 2007 | 68 | 0.070 |
Why?
| | Exons | 1 | 2008 | 349 | 0.070 |
Why?
| | Motor Vehicles | 1 | 2007 | 32 | 0.070 |
Why?
| | Judgment | 1 | 2007 | 64 | 0.070 |
Why?
| | Homoserine | 1 | 2006 | 6 | 0.070 |
Why?
| | Aged, 80 and over | 1 | 2019 | 7593 | 0.070 |
Why?
| | 4-Butyrolactone | 1 | 2006 | 21 | 0.070 |
Why?
| | Biomarkers | 2 | 2021 | 4172 | 0.070 |
Why?
| | Blood Pressure | 1 | 2013 | 1776 | 0.060 |
Why?
| | Adoption | 1 | 2006 | 32 | 0.060 |
Why?
| | Body Temperature Regulation | 1 | 2007 | 98 | 0.060 |
Why?
| | South Africa | 1 | 2006 | 219 | 0.060 |
Why?
| | Lipoxygenase | 1 | 2025 | 18 | 0.060 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2007 | 233 | 0.060 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 2025 | 77 | 0.060 |
Why?
| | Data Interpretation, Statistical | 1 | 2007 | 352 | 0.060 |
Why?
| | Reflex, Startle | 1 | 2005 | 66 | 0.060 |
Why?
| | Functional Neuroimaging | 2 | 2017 | 76 | 0.060 |
Why?
| | Hippocampus | 2 | 2022 | 903 | 0.060 |
Why?
| | Receptors, Nicotinic | 1 | 2007 | 338 | 0.060 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2025 | 158 | 0.060 |
Why?
| | Patient Education as Topic | 2 | 2009 | 766 | 0.060 |
Why?
| | Calcium Signaling | 1 | 2006 | 253 | 0.060 |
Why?
| | Social Perception | 1 | 2005 | 114 | 0.060 |
Why?
| | Risk | 1 | 2007 | 905 | 0.060 |
Why?
| | Environment | 1 | 2006 | 362 | 0.050 |
Why?
| | Cold Temperature | 1 | 2025 | 177 | 0.050 |
Why?
| | Food Preferences | 2 | 2017 | 120 | 0.050 |
Why?
| | Pseudomonas aeruginosa | 1 | 2006 | 353 | 0.050 |
Why?
| | Minority Groups | 1 | 2025 | 269 | 0.050 |
Why?
| | Patient Satisfaction | 2 | 2009 | 657 | 0.050 |
Why?
| | Social Class | 1 | 2025 | 277 | 0.050 |
Why?
| | Habits | 1 | 2023 | 49 | 0.050 |
Why?
| | Contraception Behavior | 2 | 2018 | 102 | 0.050 |
Why?
| | New Mexico | 2 | 2014 | 94 | 0.050 |
Why?
| | Models, Theoretical | 2 | 2008 | 576 | 0.050 |
Why?
| | Time Factors | 2 | 2011 | 6817 | 0.050 |
Why?
| | Genetics, Population | 1 | 2004 | 210 | 0.050 |
Why?
| | Gene Frequency | 1 | 2004 | 521 | 0.050 |
Why?
| | Child Behavior | 1 | 2004 | 248 | 0.050 |
Why?
| | Chi-Square Distribution | 2 | 2009 | 533 | 0.050 |
Why?
| | Pregnancy | 3 | 2012 | 6745 | 0.050 |
Why?
| | Smokers | 1 | 2023 | 148 | 0.050 |
Why?
| | Risk Assessment | 1 | 2011 | 3439 | 0.050 |
Why?
| | Patient Acceptance of Health Care | 2 | 2012 | 809 | 0.050 |
Why?
| | Agoraphobia | 1 | 2001 | 8 | 0.050 |
Why?
| | Physicians, Women | 1 | 2002 | 83 | 0.050 |
Why?
| | Harm Reduction | 1 | 2021 | 39 | 0.050 |
Why?
| | Exercise Tolerance | 1 | 2023 | 278 | 0.040 |
Why?
| | Georgia | 1 | 2021 | 84 | 0.040 |
Why?
| | Obsessive-Compulsive Disorder | 1 | 2001 | 46 | 0.040 |
Why?
| | Models, Genetic | 1 | 2004 | 607 | 0.040 |
Why?
| | Algorithms | 1 | 2008 | 1702 | 0.040 |
Why?
| | Psychomotor Disorders | 1 | 2020 | 14 | 0.040 |
Why?
| | Suicide, Attempted | 1 | 2024 | 374 | 0.040 |
Why?
| | Eating | 2 | 2014 | 380 | 0.040 |
Why?
| | Quality of Life | 1 | 2012 | 2870 | 0.040 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2015 | 784 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2015 | 2066 | 0.040 |
Why?
| | Verbal Learning | 1 | 2020 | 66 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2024 | 778 | 0.040 |
Why?
| | Spouses | 1 | 2000 | 105 | 0.040 |
Why?
| | Residence Characteristics | 1 | 2022 | 354 | 0.040 |
Why?
| | School Health Services | 1 | 2002 | 243 | 0.040 |
Why?
| | Substance Abuse, Intravenous | 1 | 2000 | 114 | 0.040 |
Why?
| | Pain Management | 1 | 2022 | 363 | 0.040 |
Why?
| | Quality Indicators, Health Care | 1 | 2021 | 310 | 0.040 |
Why?
| | Methylation | 1 | 2018 | 237 | 0.040 |
Why?
| | Immunity, Innate | 1 | 2024 | 832 | 0.040 |
Why?
| | Postural Balance | 1 | 2020 | 209 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2022 | 549 | 0.030 |
Why?
| | Achievement | 1 | 2018 | 61 | 0.030 |
Why?
| | Personality Assessment | 1 | 1997 | 84 | 0.030 |
Why?
| | Benzazepines | 1 | 2017 | 39 | 0.030 |
Why?
| | Psychomotor Performance | 1 | 2020 | 326 | 0.030 |
Why?
| | Tobacco Smoking | 1 | 2017 | 28 | 0.030 |
Why?
| | Social Adjustment | 1 | 2017 | 63 | 0.030 |
Why?
| | Placebo Effect | 1 | 2017 | 56 | 0.030 |
Why?
| | Beverages | 1 | 2017 | 70 | 0.030 |
Why?
| | Family | 1 | 2001 | 667 | 0.030 |
Why?
| | Organ Size | 1 | 2017 | 479 | 0.030 |
Why?
| | Self-Assessment | 1 | 1996 | 75 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2004 | 3546 | 0.030 |
Why?
| | Anticipation, Psychological | 1 | 2015 | 23 | 0.030 |
Why?
| | Smoking Prevention | 2 | 2007 | 188 | 0.030 |
Why?
| | Drive | 1 | 2014 | 2 | 0.030 |
Why?
| | Anesthesia Recovery Period | 1 | 1994 | 16 | 0.030 |
Why?
| | Anesthesia, Inhalation | 1 | 1994 | 9 | 0.030 |
Why?
| | Anesthesia, Intravenous | 1 | 1994 | 16 | 0.030 |
Why?
| | Pandemics | 1 | 2023 | 1619 | 0.030 |
Why?
| | Bulimia | 1 | 2014 | 25 | 0.030 |
Why?
| | Energy Intake | 1 | 2017 | 478 | 0.030 |
Why?
| | Retrospective Studies | 3 | 2019 | 15628 | 0.030 |
Why?
| | Event-Related Potentials, P300 | 1 | 2013 | 14 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2015 | 434 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 1002 | 0.030 |
Why?
| | Drug Interactions | 1 | 2015 | 409 | 0.030 |
Why?
| | Drug-Seeking Behavior | 1 | 2013 | 22 | 0.030 |
Why?
| | Thinness | 1 | 2014 | 91 | 0.030 |
Why?
| | Ambulatory Surgical Procedures | 1 | 1994 | 65 | 0.030 |
Why?
| | Practice Patterns, Physicians' | 1 | 2022 | 1312 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2018 | 1255 | 0.030 |
Why?
| | Predictive Value of Tests | 2 | 2013 | 2039 | 0.030 |
Why?
| | Evoked Potentials | 1 | 2013 | 132 | 0.020 |
Why?
| | Quality Control | 1 | 2013 | 171 | 0.020 |
Why?
| | Wechsler Scales | 1 | 2012 | 55 | 0.020 |
Why?
| | Motion | 1 | 2013 | 101 | 0.020 |
Why?
| | Acoustic Stimulation | 1 | 2013 | 344 | 0.020 |
Why?
| | Personality | 1 | 2013 | 131 | 0.020 |
Why?
| | Memory, Short-Term | 1 | 2014 | 269 | 0.020 |
Why?
| | Life Change Events | 1 | 2012 | 153 | 0.020 |
Why?
| | Image Enhancement | 1 | 2013 | 194 | 0.020 |
Why?
| | Alleles | 1 | 2014 | 891 | 0.020 |
Why?
| | Contraceptives, Oral | 1 | 2011 | 43 | 0.020 |
Why?
| | Psychological Tests | 1 | 2011 | 139 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2018 | 2838 | 0.020 |
Why?
| | Respiratory Tract Diseases | 1 | 2012 | 187 | 0.020 |
Why?
| | Global Health | 1 | 2012 | 386 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2011 | 377 | 0.020 |
Why?
| | Temperance | 1 | 2009 | 13 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2013 | 746 | 0.020 |
Why?
| | Pain Measurement | 1 | 2011 | 552 | 0.020 |
Why?
| | Women's Health | 1 | 2011 | 371 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 1950 | 0.020 |
Why?
| | Precision Medicine | 1 | 2012 | 426 | 0.020 |
Why?
| | Oxygen | 1 | 2012 | 943 | 0.020 |
Why?
| | DNA Primers | 1 | 2008 | 514 | 0.020 |
Why?
| | Administration, Cutaneous | 1 | 2007 | 128 | 0.020 |
Why?
| | Activities of Daily Living | 1 | 2011 | 414 | 0.020 |
Why?
| | Inositol 1,4,5-Trisphosphate Receptors | 1 | 2006 | 31 | 0.020 |
Why?
| | NIH 3T3 Cells | 1 | 2006 | 144 | 0.020 |
Why?
| | Homosexuality | 1 | 2006 | 18 | 0.020 |
Why?
| | Cytosol | 1 | 2006 | 227 | 0.020 |
Why?
| | Parents | 1 | 2014 | 1363 | 0.020 |
Why?
| | Twins, Dizygotic | 1 | 2006 | 183 | 0.020 |
Why?
| | Social Values | 1 | 2005 | 37 | 0.010 |
Why?
| | Stereotyping | 1 | 2005 | 46 | 0.010 |
Why?
| | Siblings | 1 | 2006 | 228 | 0.010 |
Why?
| | Twins, Monozygotic | 1 | 2006 | 213 | 0.010 |
Why?
| | Virulence Factors | 1 | 2006 | 167 | 0.010 |
Why?
| | Nicotine | 1 | 2007 | 338 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 974 | 0.010 |
Why?
| | Data Collection | 1 | 2007 | 674 | 0.010 |
Why?
| | Endoplasmic Reticulum | 1 | 2006 | 265 | 0.010 |
Why?
| | Binding Sites | 1 | 2007 | 1310 | 0.010 |
Why?
| | Age Distribution | 1 | 2004 | 391 | 0.010 |
Why?
| | Sex Distribution | 1 | 2004 | 378 | 0.010 |
Why?
| | Marital Status | 1 | 2002 | 44 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2006 | 1185 | 0.010 |
Why?
| | Ontario | 1 | 2002 | 156 | 0.010 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2002 | 83 | 0.010 |
Why?
| | Poverty Areas | 1 | 2002 | 39 | 0.010 |
Why?
| | Parent-Child Relations | 1 | 2004 | 272 | 0.010 |
Why?
| | Models, Educational | 1 | 2002 | 93 | 0.010 |
Why?
| | DNA | 1 | 2008 | 1460 | 0.010 |
Why?
| | Fibroblasts | 1 | 2006 | 990 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2006 | 780 | 0.010 |
Why?
| | Obstetrics | 1 | 2002 | 166 | 0.010 |
Why?
| | Gynecology | 1 | 2002 | 178 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2007 | 2615 | 0.010 |
Why?
| | Animals | 2 | 2012 | 37011 | 0.010 |
Why?
| | Apoptosis | 1 | 2006 | 2557 | 0.010 |
Why?
| | Ambulatory Care | 1 | 2001 | 539 | 0.010 |
Why?
| | Surgery, Oral | 1 | 1994 | 6 | 0.010 |
Why?
| | Enflurane | 1 | 1994 | 4 | 0.010 |
Why?
| | Halothane | 1 | 1994 | 7 | 0.010 |
Why?
| | Cohort Studies | 1 | 2004 | 5730 | 0.010 |
Why?
| | Isoflurane | 1 | 1994 | 31 | 0.010 |
Why?
| | Eye Movements | 1 | 1994 | 67 | 0.010 |
Why?
| | Propofol | 1 | 1994 | 73 | 0.010 |
Why?
| | Mice | 1 | 2006 | 17843 | 0.000 |
Why?
|
|
Bryan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|